Hedge Fund Beats Vaxart Investor's 'Short-Swing' Profits Suit
A New York federal judge has granted a win to hedge fund Armistice Capital LLC and its managing member in a derivative suit brought by a shareholder of biotechnology company Vaxart...To view the full article, register now.
Already a subscriber? Click here to view full article